Support opportunities

To discover how your company could support this foremost event for the rare disease community, please contact:

Céline Schwob
Corporate Relations Manager
EURORDIS-Rare Diseases Europe
[email protected] or +33 1 56 53 52 16

 

With thanks to our 2022 corporate donors

Alexion
Biogen
Biomarin Logo RGB (used for ECRD2020)
boehringer
Chiesi logo
CSLBehring_tagline_below_RGB_TM_88mm
Horizon
ipsen
janssen
KyowaKirin_BrandLogo_color
novartis_logo_rgb_pos
Orchard
Pfizer logo
Copy of PTC_Therapeutic
Roche
Logo_Sanofi_2022-300x138
Takeda
ultragenyxPH-CMYK
Vertex

Why are corporate donors attending ECRD2022

 

Ahead of #ECRD2022 online from 27 June to 1 July 2022, we hear from 2 leaders from the pharmaceutical industry on the reasons why they are attending the conference:

“We need to make sure that policies are adequately ready. But no one – no payer, no government, no company – can make these changes on its own.”

These words of Dirk Vander Mijnsbrugge from Pfizer, one of the companies supporting the European Conference on Rare Diseases and Orphan Products, confirm the importance of a collaborative effort to address the needs of people with rare diseases.

 

 

“There really is no better time than now to rethink and rework the rare disease eco-system and forge meaningful partnerships to drive for greater action.”

Ricardo Marek, President of the Growth & Emerging Markets Business Unit at Takeda, reasserted the urgency of taking action now for the 30 million Europeans living with a rare disease

Organised by:

Co-organised by:

 

With the support of

AFM logo

EU funding logo